MedPath

Does giving calcium during cesarean section help reduce blood loss? A study on High Risk Mothers

Not yet recruiting
Conditions
Third-stage hemorrhage,
Registration Number
CTRI/2025/05/087002
Lead Sponsor
JIPMER Intramural Research fund
Brief Summary

This study is a randomized, double blinded, placebo controlled trial accessing the effectiveness of calcium gluconate in reducing blood loss in during cesarean section. The main purpose of this study is to whether giving intravenous calcium gluconate will reduce postpartum bleeding in high-risk pregnancy like, twins, previous cesarean section, obese patients, etc. As calcium gluconate is readily available, cheap and economic, using it for the management of postpartum bleeding will be very effective. Similar studies have been done in normal healthy pregnant women and found to show positive results. So, we have extended it the next level, trying to evaluate its effect in high-risk pregnancy.  The primary objective of this study is to estimate blood loss and secondary outcomes are to compare preoperative and postoperative ionized calcium levels and hemoglobin level by doing a venous blood gas analysis, accessing the uterine tone and monitoring changes in blood pressures and heart rate. The proposed hypothesis is that intravenous calcium gluconate is effective in reducing blood loss in women posted for cesarean section with risk factor for postpartum hemorrhage.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
180
Inclusion Criteria

Age 18 years and more ASA 2 and 3 Gestational age more than 34 weeks Planned for c-section under spinal anesthesia Pregnant females with high risk for blood loss during c-section like previous cesarean section, twin pregnancy, severe obesity, history of previous postpartum hemorrhage.

Exclusion Criteria

Pregnant females with heart disease, chronic renal disease, placenta accreta sprectum, pregnant females who are taking calcium channel blockers like nifedipine tablets.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effect of intravenous calcium gluconate with placebo on reduction of intrapartum blood loss in pregnant women posted for cesarean section with risk factor of postpartum hemorrhage.At the end of the surgery
Secondary Outcome Measures
NameTimeMethod
1.verbal numerical rating scale of uterine tone2.baseline & postoperative hemoglobin

Trial Locations

Locations (1)

Jawaharlal Institute of Postgradute Medical Education and Research

🇮🇳

Pondicherry, PONDICHERRY, India

Jawaharlal Institute of Postgradute Medical Education and Research
🇮🇳Pondicherry, PONDICHERRY, India
DrAdhithya
Principal investigator
8667637183
artsage17@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.